It has also been reported that ABL kinases protected tumor cells from apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) (40) and that a high expression level of RUNX2 is associated with poor prognosis in patients with osteosarcoma (41). Here, TNFSF10 is linked to osteosarcoma.